Document is current
Any future updates will be listed below
-
Authors
Di Mauro, Giuseppe
Pachetti, Maria
Ploner, Christian
De Luca, Michele
Pellegrini, Graziella
Gambini, Elisa
Moretti, Massimo
Sfiligoj, Antonio
Yordanov, Teodor E.
Knezevic, Miomir
Sidoti, Giulia Benedetta
Papa, Giovanni
Zacchigna, Serena
-
Funding
Funding for this research was provided by:
Interreg (PROMOS)
Interreg (COHERENCE)
- License Information
-
More Information
Article History
Received: 3 March 2026
Accepted: 11 May 2026
First Online: 23 May 2026
Declarations
:
: Not applicable.
: Not applicable.
: M.M. is an employee of VivaBiocell SpA; T.E.Y. is the CSO of AngiosFlex Co.; E.G. is the COO-CTO of Oloker Therapeutics one of the co-inventors of the CPCPlus technology. The company was not involved in the drafting of this manuscript and has no direct financial interest in the content of this publication. All of them can potentially have conflict of interest. M.D.L. and G.Pe. have no conflict of interest, the company was closed and they are not on board with the new company. The other authors do not have competing interests.
